The Market was up again last week, about 4%, following its prior gains. Last week’s top five stocks that reached 52-week lows were: Abbott Laboratories, Baxter International Inc., McCormick & Company Inc, Teleflex Inc, And Chattem Inc..
Last week's top two out of favor industries were the Health Care Equipment and Services and Industries Goods and Services industries. 4 Health Care Equipment and Services stocks have reached their 52-week lows, while 1 has reached its 52-week high, giving the industry a low/high ratio of 4. In the Industrial Goods and Services industry, 8 stocks have reached their 52-week lows, while 3 have reached their 52-week highs, giving the industry a low/high ratio of 2.67.
For full details about guru stocks at 52-week lows and more information, click here: http://www.gurufocus.com/52weeklow.php.
Abbott Laboratories (ABT, Financial) Reached the 52-Week Low of $44.12
The prices of Abbott Laboratories (ABT) shares have declined to close to the 52-week low of $44.12, which is 26.2% off the 52-week high of $59.81. Abbott Laboratories is owned by 8 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 5 reduced their positions.
Abbott Laboratories is a global broad-based health care company devoted to discovering new medicines new technologies and new ways to manage health. The company has a market cap of $68.18 billion; its shares were traded at around $44.12 with a P/E ratio of 13.2 and P/S ratio of 2.2. The dividend yield of Abbott Laboratories stocks is 3.3%. Abbott Laboratories had an annual average earning growth of 4.4% over the past 10 years. GuruFocus rated Abbott Laboratories the business predictability rank of 5-star.
Abbott Laboratories recently announced that it would report its first quarter 2009 financial results on Wednesday, April 15, 2009, before the market opens.
Ken Heebner owns 9,335,000 shares as of 12/31/2008, an increase of 18.16% from the previous quarter. This position accounts for 7.26% of the $6.87 billion portfolio of CAPITAL GROWTH MANAGEMENT LP. Kenneth Fisher owns 15,221 shares as of 12/31/2008, a decrease of 37.71% of from the previous quarter. This position accounts for less than 0.01% of the $23.44 billion portfolio of Fisher Asset Management, LLC. Brian Rogers sold out his holdings in the quarter that ended on 12/31/2008.
Sell: Chairman and CEO Miles D White sold 150,000 shares of ABT stock on 03/16/2009 at the average price of $47.5; the price of the stock has decreased by 7.12% since.
Baxter International Inc. (BAX, Financial) Reached the 52-Week Low of $48.61
The prices of Baxter International Inc. (BAX) shares have declined to close to the 52-week low of $48.61, which is 31.8% off the 52-week high of $71.15. Baxter International Inc. is owned by 7 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 5 reduced their positions.
Baxter engages in the worldwide development manufacture and distribution of a diversified line of products systems and services used primarily in the health-care field. The company has a market cap of $29.57 billion; its shares were traded at around $48.61 with a P/E ratio of 14.4 and P/S ratio of 2.4. The dividend yield of Baxter International Inc. stocks is 2.2%. Baxter International Inc. had an annual average earning growth of 4.8% over the past 10 years. GuruFocus rated Baxter International Inc. the business predictability rank of 4-star.
Ken Heebner owns 6,187,700 shares as of 12/31/2008, an increase of 280.15% from the previous quarter. This position accounts for 4.83% of the $6.87 billion portfolio of CAPITAL GROWTH MANAGEMENT LP. Dodge & Cox owns 9,428 shares as of 12/31/2008, a decrease of 20.29% of from the previous quarter. This position accounts for less than 0.01% of the $65.51 billion portfolio of Dodge & Cox. John Rogers owns 675,819 shares as of 12/31/2008, a decrease of 43.11% of from the previous quarter. This position accounts for 0.87% of the $4.14 billion portfolio of ARIEL CAPITAL MANAGEMENT LLC.
Buy: Director Blake E Devitt bought 1,500 shares of BAX stock on 11/20/2008 at the average price of $51.61; the price of the stock has decreased by 5.81% since.
McCormick & Company Inc. (MKC, Financial) Reached the 52-Week Low of $29.28
The prices of McCormick & Company Inc. (MKC) shares have declined to close to the 52-week low of $29.28, which is 31.4% off the 52-week high of $41.97. McCormick & Company Inc. is owned by 3 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 1 reduced his position in the company.
McCormick & Company a diversified specialty food company is a global leader in the manufacture marketing and distribution of spices and other goods. The company has a market cap of $3.81 billion; its shares were traded at around $29.28 with a P/E ratio of 13.4 and P/S ratio of 1.2. The dividend yield of McCormick & Company Inc. stocks is 3.3%. McCormick & Company Inc. had an annual average earning growth of 10.1% over the past 10 years. GuruFocus rated McCormick & Company Inc. the business predictability rank of 5-star.
McCormick & Company recently reported its first quarter 2009 results. The company announced that its sales were up 7% in local currency, but changing exchange rates of currency caused the company's sales to drop 8%. The company also reported an EPS of 44 cents, up 7% when compared to the company's first quarter 2008 results.
John Hussman bought 750,000 shares in the quarter that ended on 12/31/2008, which is 0.71% of the $3.37 billion portfolio of Hussman Economtrics Advisors, Inc.. Brian Rogers owns 2,000,000 shares as of 12/31/2008, which accounts for 0.47% of the $13.49 billion portfolio of T Rowe Price Equity Income Fund. Mark Hillman owns 23,246 shares as of 12/31/2008, a decrease of 25.03% of from the previous quarter. This position accounts for 0.24% of the $308 million portfolio of Hillman Capital Management.
Teleflex Inc. (TFX, Financial) Reached the 52-Week Low of
Teleflex is a growth-oriented company managed for long-term consistent performance. has a market cap of $1.55 billion; its shares were traded at around $39.08 with a P/E ratio of 9.7 and P/S ratio of 0.6. The dividend yield of Teleflex Inc. stocks is 3.5%. Teleflex Inc. had an annual average earning growth of 6.5% over the past 10 years. GuruFocus rated Teleflex Inc. the business predictability rank of 2-star.
Teleflex Inc. recently reported its fourth quarter and full year 2008 results. The company said that that its fourth quarter diluted earnings per share was $1.04, up 47% compared to the fourth quarter of 2007. Net income was $19.6 million, or $0.49 per diluted share compared to $65.4 million, or $1.66 per diluted share in the prior year quarter. “The solid performance of our core operations reflects the strength of our businesses and our management teams’ ability to execute,” said Jeffrey P. Black, chairman and chief executive officer of Teleflex.
David Dreman bought 57,600 shares in the quarter that ended on 12/31/2008, which is 0.04% of the $7.73 billion portfolio of Dreman Value Management. Robert Olstein owns 303,201 shares as of 12/31/2008, which accounts for 3.2% of the $474 million portfolio of Olstein Financial Alert Fund.
Buy: Director Patricia C Barron bought 1,200 shares of TFX stock on 11/21/2008 at the average price of $41.03; the price of the stock has decreased by 4.75% since.
Chattem Inc. (CHTT, Financial) Reached the 52-Week Low of
Chattem Inc. is a leading marketer and manufacturer of a variety of branded consumer products including over-the-counter health care and toiletries and skin care products. The company has a market cap of $1.01 billion; its shares were traded at around $52 with a P/E ratio of 13.1 and P/S ratio of 2.3. Chattem Inc. had an annual average earning growth of 8.9% over the past 10 years. GuruFocus rated Chattem Inc. the business predictability rank of 2.5-star.
Chattem Inc. recently reported its fourth quarter and full year 2008 results. The company announced that its revenues for fiscal 2008 rose to a record $454.9 million, up 7.4%, compared to revenues of $423.4 million in fiscal 2007. “The Company’s growth and momentum continued in fiscal 2008 with strong revenue and earnings growth,” said Zan Guerry, Chattem’s Chairman and Chief Executive Officer. “Product innovation and a commitment to our advertising strategy behind our key brands, Gold Bond®, ACT®, Icy Hot® and Cortizone-10®, continues to drive our revenues, earnings and cash generation. In addition to funding our operations, the cash flow of the business allowed us to continue to reduce debt, opportunistically repurchase shares of our common stock, fund the settlement of Dexatrim® claims and increase our year-end cash balances,” Guerry stated.
Sell: Director Philip H Sanford sold 2,000 shares of CHTT stock on 02/02/2009 at the average price of $66.33; the price of the stock has decreased by 21.6% since.
Go here for the complete list of 52-week lows.
Last week's top two out of favor industries were the Health Care Equipment and Services and Industries Goods and Services industries. 4 Health Care Equipment and Services stocks have reached their 52-week lows, while 1 has reached its 52-week high, giving the industry a low/high ratio of 4. In the Industrial Goods and Services industry, 8 stocks have reached their 52-week lows, while 3 have reached their 52-week highs, giving the industry a low/high ratio of 2.67.
For full details about guru stocks at 52-week lows and more information, click here: http://www.gurufocus.com/52weeklow.php.
Abbott Laboratories (ABT, Financial) Reached the 52-Week Low of $44.12
The prices of Abbott Laboratories (ABT) shares have declined to close to the 52-week low of $44.12, which is 26.2% off the 52-week high of $59.81. Abbott Laboratories is owned by 8 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 5 reduced their positions.
Abbott Laboratories is a global broad-based health care company devoted to discovering new medicines new technologies and new ways to manage health. The company has a market cap of $68.18 billion; its shares were traded at around $44.12 with a P/E ratio of 13.2 and P/S ratio of 2.2. The dividend yield of Abbott Laboratories stocks is 3.3%. Abbott Laboratories had an annual average earning growth of 4.4% over the past 10 years. GuruFocus rated Abbott Laboratories the business predictability rank of 5-star.
Abbott Laboratories recently announced that it would report its first quarter 2009 financial results on Wednesday, April 15, 2009, before the market opens.
Ken Heebner owns 9,335,000 shares as of 12/31/2008, an increase of 18.16% from the previous quarter. This position accounts for 7.26% of the $6.87 billion portfolio of CAPITAL GROWTH MANAGEMENT LP. Kenneth Fisher owns 15,221 shares as of 12/31/2008, a decrease of 37.71% of from the previous quarter. This position accounts for less than 0.01% of the $23.44 billion portfolio of Fisher Asset Management, LLC. Brian Rogers sold out his holdings in the quarter that ended on 12/31/2008.
Sell: Chairman and CEO Miles D White sold 150,000 shares of ABT stock on 03/16/2009 at the average price of $47.5; the price of the stock has decreased by 7.12% since.
Baxter International Inc. (BAX, Financial) Reached the 52-Week Low of $48.61
The prices of Baxter International Inc. (BAX) shares have declined to close to the 52-week low of $48.61, which is 31.8% off the 52-week high of $71.15. Baxter International Inc. is owned by 7 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 5 reduced their positions.
Baxter engages in the worldwide development manufacture and distribution of a diversified line of products systems and services used primarily in the health-care field. The company has a market cap of $29.57 billion; its shares were traded at around $48.61 with a P/E ratio of 14.4 and P/S ratio of 2.4. The dividend yield of Baxter International Inc. stocks is 2.2%. Baxter International Inc. had an annual average earning growth of 4.8% over the past 10 years. GuruFocus rated Baxter International Inc. the business predictability rank of 4-star.
Ken Heebner owns 6,187,700 shares as of 12/31/2008, an increase of 280.15% from the previous quarter. This position accounts for 4.83% of the $6.87 billion portfolio of CAPITAL GROWTH MANAGEMENT LP. Dodge & Cox owns 9,428 shares as of 12/31/2008, a decrease of 20.29% of from the previous quarter. This position accounts for less than 0.01% of the $65.51 billion portfolio of Dodge & Cox. John Rogers owns 675,819 shares as of 12/31/2008, a decrease of 43.11% of from the previous quarter. This position accounts for 0.87% of the $4.14 billion portfolio of ARIEL CAPITAL MANAGEMENT LLC.
Buy: Director Blake E Devitt bought 1,500 shares of BAX stock on 11/20/2008 at the average price of $51.61; the price of the stock has decreased by 5.81% since.
McCormick & Company Inc. (MKC, Financial) Reached the 52-Week Low of $29.28
The prices of McCormick & Company Inc. (MKC) shares have declined to close to the 52-week low of $29.28, which is 31.4% off the 52-week high of $41.97. McCormick & Company Inc. is owned by 3 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 1 reduced his position in the company.
McCormick & Company a diversified specialty food company is a global leader in the manufacture marketing and distribution of spices and other goods. The company has a market cap of $3.81 billion; its shares were traded at around $29.28 with a P/E ratio of 13.4 and P/S ratio of 1.2. The dividend yield of McCormick & Company Inc. stocks is 3.3%. McCormick & Company Inc. had an annual average earning growth of 10.1% over the past 10 years. GuruFocus rated McCormick & Company Inc. the business predictability rank of 5-star.
McCormick & Company recently reported its first quarter 2009 results. The company announced that its sales were up 7% in local currency, but changing exchange rates of currency caused the company's sales to drop 8%. The company also reported an EPS of 44 cents, up 7% when compared to the company's first quarter 2008 results.
John Hussman bought 750,000 shares in the quarter that ended on 12/31/2008, which is 0.71% of the $3.37 billion portfolio of Hussman Economtrics Advisors, Inc.. Brian Rogers owns 2,000,000 shares as of 12/31/2008, which accounts for 0.47% of the $13.49 billion portfolio of T Rowe Price Equity Income Fund. Mark Hillman owns 23,246 shares as of 12/31/2008, a decrease of 25.03% of from the previous quarter. This position accounts for 0.24% of the $308 million portfolio of Hillman Capital Management.
Teleflex Inc. (TFX, Financial) Reached the 52-Week Low of
Teleflex is a growth-oriented company managed for long-term consistent performance. has a market cap of $1.55 billion; its shares were traded at around $39.08 with a P/E ratio of 9.7 and P/S ratio of 0.6. The dividend yield of Teleflex Inc. stocks is 3.5%. Teleflex Inc. had an annual average earning growth of 6.5% over the past 10 years. GuruFocus rated Teleflex Inc. the business predictability rank of 2-star.
Teleflex Inc. recently reported its fourth quarter and full year 2008 results. The company said that that its fourth quarter diluted earnings per share was $1.04, up 47% compared to the fourth quarter of 2007. Net income was $19.6 million, or $0.49 per diluted share compared to $65.4 million, or $1.66 per diluted share in the prior year quarter. “The solid performance of our core operations reflects the strength of our businesses and our management teams’ ability to execute,” said Jeffrey P. Black, chairman and chief executive officer of Teleflex.
David Dreman bought 57,600 shares in the quarter that ended on 12/31/2008, which is 0.04% of the $7.73 billion portfolio of Dreman Value Management. Robert Olstein owns 303,201 shares as of 12/31/2008, which accounts for 3.2% of the $474 million portfolio of Olstein Financial Alert Fund.
Buy: Director Patricia C Barron bought 1,200 shares of TFX stock on 11/21/2008 at the average price of $41.03; the price of the stock has decreased by 4.75% since.
Chattem Inc. (CHTT, Financial) Reached the 52-Week Low of
Chattem Inc. is a leading marketer and manufacturer of a variety of branded consumer products including over-the-counter health care and toiletries and skin care products. The company has a market cap of $1.01 billion; its shares were traded at around $52 with a P/E ratio of 13.1 and P/S ratio of 2.3. Chattem Inc. had an annual average earning growth of 8.9% over the past 10 years. GuruFocus rated Chattem Inc. the business predictability rank of 2.5-star.
Chattem Inc. recently reported its fourth quarter and full year 2008 results. The company announced that its revenues for fiscal 2008 rose to a record $454.9 million, up 7.4%, compared to revenues of $423.4 million in fiscal 2007. “The Company’s growth and momentum continued in fiscal 2008 with strong revenue and earnings growth,” said Zan Guerry, Chattem’s Chairman and Chief Executive Officer. “Product innovation and a commitment to our advertising strategy behind our key brands, Gold Bond®, ACT®, Icy Hot® and Cortizone-10®, continues to drive our revenues, earnings and cash generation. In addition to funding our operations, the cash flow of the business allowed us to continue to reduce debt, opportunistically repurchase shares of our common stock, fund the settlement of Dexatrim® claims and increase our year-end cash balances,” Guerry stated.
Sell: Director Philip H Sanford sold 2,000 shares of CHTT stock on 02/02/2009 at the average price of $66.33; the price of the stock has decreased by 21.6% since.
Go here for the complete list of 52-week lows.
